Stat3-targeted therapies overcome the acquired resistance to vemurafenib in melanomas.
Liu F; Cao J; Wu J; Sullivan K; Shen J; Ryu B; Xu Z; Wei W; Cui R; The Journal Of Investigative Dermatology, 2013, vol. 133, issue 8, p 2041, ISSN 15231747. ISBN 15231747.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef